Insider Shareholders with Direct Ownership of Sab Biotherapeutics, Inc. (SABS)
This section provides a comprehensive overview of the insiders with direct ownership of Sab Biotherapeutics, Inc. (SABS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SAB Biotherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Eddie Joe Sullivan
PRESIDENT |
5,232,304 | 0 | 5,232,304 $21.2 Million | 4 |
Dec 07, 2023
Added 0.03%
|
| 5,084,351 | 0 | 4,993,090 $20.2 Million | 3 |
Sep 13, 2022
Added 0.2%
|
|
|
Edward D. Hamilton
> 10% Shareholder |
5,003,084 | 0 | 4,974,497 $20.1 Million | 4 |
Oct 22, 2021
Added 50.0%
|
|
Sessa Capital (Master), L.P.
Director |
4,584,571 | 0 | 4,584,571 $18.6 Million | 1 |
Nov 24, 2023
Added 50.0%
|
|
Big Cypress Holdings Llc
CEO and CFO |
417,200 | 0 | 3,047,825 $12.3 Million | 1 |
Jan 14, 2021
Added 12.04%
|
| 394,989 | 0 | 394,989 $1.6 Million | 3 |
Dec 07, 2022
Added 17.36%
|
|
|
Alexandra Kropotova
CHIEF MEDICAL OFFICER |
575,000 | 0 | 275,000 $1.11 Million | 2 |
Mar 14, 2023
Added 50.0%
|
|
Samuel J Reich
CEO & EXECUTIVE CHAIRMAN |
219,001 | 0 | 219,001 $886,954 | 3 |
Nov 29, 2023
Added 4.78%
|
| 57,313 | 0 | 57,313 $232,117 | 2 |
Dec 07, 2022
Added 41.99%
|
|
|
Frederick Finnegan
Chief Business Officer |
38,596 | 0 | 38,596 $156,313 | 1 |
Oct 22, 2021
Added 50.0%
|
|
Thomas Charles Luke
Chief Medical Officer |
6,418 | 0 | 5,428 $21,983 | 2 |
Oct 22, 2021
Added 50.0%
|
|
Michael King
CHIEF FINANCIAL OFFICER |
5,000 | 0 | 5,000 $20,250 | 1 |
Nov 30, 2023
Added 50.0%
|
|
Russell P Beyer
Chief Financial Officer |
2,475 | 0 | 2,475 $10,023 | 1 |
Oct 18, 2021
Added 50.0%
|
|
Ilan Katz
Director |
1,500 | 0 | 1,500 $6,075 | 2 |
Oct 13, 2021
Added 25.0%
|